Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Filipits

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
Current Opinion in Oncology|January 21, 2014
New developments in the treatment of squamous cell lung cancerMartin Filipits
Clinical Lung Cancer|October 13, 2018
Adjuvant Therapy in Patients With Completely Resected Non-small-cell Lung Cancer: Current Status and PerspectivesRobert Pirker, Martin Filipits
Lung Cancer (Amsterdam, Netherlands)|September 3, 2011
Predictive markers in the adjuvant therapy of non-small cell lung cancerMartin Filipits, Robert Pirker
Wiener Medizinische Wochenschrift (1946)|December 25, 2007
[Biomarkers - the way towards individualized chemotherapy in non-small cell lung cancer (NSCLC)]Sabine Danzinger, Martin Filipits
Translational Lung Cancer Research|March 26, 2015
Cetuximab in non-small-cell lung cancerRobert Pirker, Martin Filipits
Critical Reviews in Oncology/Hematology|November 27, 2010
Monoclonal antibodies against EGFR in non-small cell lung cancerRobert Pirker, Martin Filipits
Translational Lung Cancer Research|January 23, 2016
Alectinib in RET-rearranged non-small cell lung cancer-Another progress in precision medicine?Robert Pirker, Martin Filipits
Cancer Metastasis Reviews|March 14, 2016
Personalized treatment of advanced non-small-cell lung cancer in routine clinical practiceRobert Pirker, Martin Filipits
Current Pharmaceutical Design|January 20, 2009
Targeted therapies in lung cancerRobert Pirker, Martin Filipits
Current Opinion in Oncology|January 6, 2016
The potential of liquid biopsiesAnna Buder, Christian Tomuta, Martin Filipits
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
Current Opinion in Oncology|January 21, 2014
New developments in the treatment of squamous cell lung cancerMartin Filipits
Clinical Lung Cancer|October 13, 2018
Adjuvant Therapy in Patients With Completely Resected Non-small-cell Lung Cancer: Current Status and PerspectivesRobert Pirker, Martin Filipits
Lung Cancer (Amsterdam, Netherlands)|September 3, 2011
Predictive markers in the adjuvant therapy of non-small cell lung cancerMartin Filipits, Robert Pirker
Wiener Medizinische Wochenschrift (1946)|December 25, 2007
[Biomarkers - the way towards individualized chemotherapy in non-small cell lung cancer (NSCLC)]Sabine Danzinger, Martin Filipits
Translational Lung Cancer Research|March 26, 2015
Cetuximab in non-small-cell lung cancerRobert Pirker, Martin Filipits
Critical Reviews in Oncology/Hematology|November 27, 2010
Monoclonal antibodies against EGFR in non-small cell lung cancerRobert Pirker, Martin Filipits
Translational Lung Cancer Research|January 23, 2016
Alectinib in RET-rearranged non-small cell lung cancer-Another progress in precision medicine?Robert Pirker, Martin Filipits
Cancer Metastasis Reviews|March 14, 2016
Personalized treatment of advanced non-small-cell lung cancer in routine clinical practiceRobert Pirker, Martin Filipits
Current Pharmaceutical Design|January 20, 2009
Targeted therapies in lung cancerRobert Pirker, Martin Filipits
Current Opinion in Oncology|January 6, 2016
The potential of liquid biopsiesAnna Buder, Christian Tomuta, Martin Filipits
Pageof 13